376 related articles for article (PubMed ID: 28858540)
21. Pancreatic intraductal papillary mucinous neoplasms: role of CT in predicting pathologic subtypes.
Gupta R; Mortelé KJ; Tatli S; Girshman J; Glickman JN; Levy AD; Erturk SM; Heffess CS; Banks PA; Silverman SG
AJR Am J Roentgenol; 2008 Nov; 191(5):1458-64. PubMed ID: 18941085
[TBL] [Abstract][Full Text] [Related]
22. Absence of a dilated duct predicts benign disease in suspected pancreas cancer: a simple clinical rule.
Rodriguez S; Faigel D
Dig Dis Sci; 2010 Apr; 55(4):1161-6. PubMed ID: 19590960
[TBL] [Abstract][Full Text] [Related]
23. Risk of misdiagnosis and overtreatment in patients with main pancreatic duct dilatation and suspected combined/main-duct intraductal papillary mucinous neoplasms.
Crippa S; Pergolini I; Rubini C; Castelli P; Partelli S; Zardini C; Marchesini G; Zamboni G; Falconi M
Surgery; 2016 Apr; 159(4):1041-9. PubMed ID: 26704784
[TBL] [Abstract][Full Text] [Related]
24. Contrast-enhanced multiphasic CT and MRI findings of adenosquamous carcinoma of the pancreas.
Ding Y; Zhou J; Sun H; He D; Zeng M; Rao S
Clin Imaging; 2013; 37(6):1054-60. PubMed ID: 24035524
[TBL] [Abstract][Full Text] [Related]
25. The abrupt pancreatic duct cutoff sign on MDCT and MRI.
Johnston A; Serhal A; Lopes Vendrami C; McCarthy RJ; Komanduri S; Horowitz JM; Nikolaidis P; Miller FH
Abdom Radiol (NY); 2020 Aug; 45(8):2476-2484. PubMed ID: 32444890
[TBL] [Abstract][Full Text] [Related]
26. Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas.
Ichikawa T; Sou H; Araki T; Arbab AS; Yoshikawa T; Ishigame K; Haradome H; Hachiya J
Radiology; 2001 Oct; 221(1):107-16. PubMed ID: 11568327
[TBL] [Abstract][Full Text] [Related]
27. Macrocystic neoplasms of the pancreas: CT differentiation of serous oligocystic adenoma from mucinous cystadenoma and intraductal papillary mucinous tumor.
Kim SY; Lee JM; Kim SH; Shin KS; Kim YJ; An SK; Han CJ; Han JK; Choi BI
AJR Am J Roentgenol; 2006 Nov; 187(5):1192-8. PubMed ID: 17056905
[TBL] [Abstract][Full Text] [Related]
28. Differentiation of large (≥ 5 cm) gastrointestinal stromal tumors from benign subepithelial tumors in the stomach: radiologists' performance using CT.
Choi YR; Kim SH; Kim SA; Shin CI; Kim HJ; Kim SH; Han JK; Choi BI
Eur J Radiol; 2014 Feb; 83(2):250-60. PubMed ID: 24325848
[TBL] [Abstract][Full Text] [Related]
29. Clinical study of chronic pancreatitis with focal irregular narrowing of the main pancreatic duct and mass formation: comparison with chronic pancreatitis showing diffuse irregular narrowing of the main pancreatic duct.
Wakabayashi T; Kawaura Y; Satomura Y; Fujii T; Motoo Y; Okai T; Sawabu N
Pancreas; 2002 Oct; 25(3):283-9. PubMed ID: 12370540
[TBL] [Abstract][Full Text] [Related]
30. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.
Harima H; Kaino S; Shinoda S; Kawano M; Suenaga S; Sakaida I
World J Gastroenterol; 2015 May; 21(20):6252-60. PubMed ID: 26034360
[TBL] [Abstract][Full Text] [Related]
31. Severe localized stenosis and marked dilatation of the main pancreatic duct are indicators of pancreatic cancer instead of chronic pancreatitis on endoscopic retrograde balloon pancreatography.
Inoue K; Ohuchida J; Ohtsuka T; Nabae T; Yokohata K; Ogawa Y; Yamaguchi K; Tanaka M
Gastrointest Endosc; 2003 Oct; 58(4):510-5. PubMed ID: 14520282
[TBL] [Abstract][Full Text] [Related]
32. Predictors of Malignancy in "Pure" Branch-Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas without Enhancing Mural Nodules on CT Imaging: A Nationwide Multicenter Study.
Kim TH; Woo YS; Chon HK; Hwang JH; Yoo KS; Lee WJ; Lee KH; Lee JK; Dong SH; Park CH; Park ET; Moon JH; Kim HG; Cho KB; Kim HJ; Lee SO; Cheon YK; Lee JM; Park JW; Kim MH
Gut Liver; 2018 Sep; 12(5):583-590. PubMed ID: 29730906
[TBL] [Abstract][Full Text] [Related]
33. Small solid tumors (< or = 2 cm) of the pancreas: relative accuracy and differentiation of CT and MR imaging.
Rao SX; Zeng MS; Cheng WZ; Yao XZ; Jin DY; Ji Y
Hepatogastroenterology; 2011; 58(107-108):996-1001. PubMed ID: 21830431
[TBL] [Abstract][Full Text] [Related]
34. CT imaging spectrum of pancreatic serous tumors: based on new pathologic classification.
Sun HY; Kim SH; Kim MA; Lee JY; Han JK; Choi BI
Eur J Radiol; 2010 Aug; 75(2):e45-55. PubMed ID: 20056368
[TBL] [Abstract][Full Text] [Related]
35. Appropriate indications of initial endoscopic ultrasound evaluation for detecting mural nodules in branch duct intraductal papillary mucinous neoplasms of the pancreas.
Kim YI; Woo SM; Lee WJ; Han SS; Park SJ; Kim TH; Koh YH; Hong EK
Scand J Gastroenterol; 2013 May; 48(5):610-6. PubMed ID: 23597152
[TBL] [Abstract][Full Text] [Related]
36. Endoscopic ultrasound in patients with normal liver blood tests and unexplained dilatation of common bile duct and or pancreatic duct.
Oppong KW; Mitra V; Scott J; Anderson K; Charnley RM; Bonnington S; Jaques B; White S; French JJ; Manas DM; Sen G; Nayar MK
Scand J Gastroenterol; 2014 Apr; 49(4):473-80. PubMed ID: 24472065
[TBL] [Abstract][Full Text] [Related]
37. Intraductal papillary mucinous neoplasms of the pancreas: radiological predictors of malignant transformation and the introduction of bile duct dilation to current guidelines.
Strauss A; Birdsey M; Fritz S; Schwarz-Bundy BD; Bergmann F; Hackert T; Kauczor HU; Grenacher L; Klauss M
Br J Radiol; 2016; 89(1061):20150853. PubMed ID: 26959611
[TBL] [Abstract][Full Text] [Related]
38. Use of MDCT to Differentiate Autoimmune Pancreatitis From Ductal Adenocarcinoma and Interstitial Pancreatitis.
Lee-Felker SA; Felker ER; Kadell B; Farrell J; Raman SS; Sayre J; Lu DS
AJR Am J Roentgenol; 2015 Jul; 205(1):2-9. PubMed ID: 26102377
[TBL] [Abstract][Full Text] [Related]
39. Assessment of malignant potential in intraductal papillary mucinous neoplasms of the pancreas using MR findings and texture analysis.
Jeon SK; Kim JH; Yoo J; Kim JE; Park SJ; Han JK
Eur Radiol; 2021 May; 31(5):3394-3404. PubMed ID: 33140171
[TBL] [Abstract][Full Text] [Related]
40. Main pancreatic duct dilatation: a sign of high risk for pancreatic cancer.
Tanaka S; Nakaizumi A; Ioka T; Oshikawa O; Uehara H; Nakao M; Yamamoto K; Ishikawa O; Ohigashi H; Kitamra T
Jpn J Clin Oncol; 2002 Oct; 32(10):407-11. PubMed ID: 12451037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
